Breaking News Instant updates and real-time market news.

DLTR

Dollar Tree

$88.68

6.69 (8.16%)

, WMT

Wal-Mart

$70.12

0.75 (1.08%)

07:24
11/23/16
11/23
07:24
11/23/16
07:24

Dollar Tree price target raised to $100 from $90 at UBS

UBS analyst Michael Lasser raised his price target on Dollar Tree (DLTR) to $100 from $90 following Q3 results. The analyst said the company's results eased a number of fears and demonstrated it could hold its own against competitors such as Wal-Mart (WMT). Dollar Tree exhibited comp growth, and its merger with Family dollar is providing synergies within its guidance, said Lasser, who reiterated his Buy rating on the shares.

DLTR

Dollar Tree

$88.68

6.69 (8.16%)

WMT

Wal-Mart

$70.12

0.75 (1.08%)

  • 01

    Dec

DLTR Dollar Tree
$88.68

6.69 (8.16%)

11/14/16
UBSW
11/14/16
NO CHANGE
Target $90
UBSW
Buy
Dollar Tree valuation is quite favorable, says UBS
UBS analyst Michael Lasser said Dollar Tree's valuation remains favorable. Lasser said top-line trends for Q3 were probably subdued but with the shares trading at a discount and its PE trading at just a sight premium to the S&P, soft trends will be reflective of a tough environment rather than a change in productivity. The analyst said margins should continue to gain as synergies with is Family Dollar acquisition accelerate. Lasser reiterated his Buy rating and $90 price target on Dollar Tree shares.
11/15/16
JRCO
11/15/16
UPGRADE
JRCO
Accumulate
Dollar Tree upgraded to Accumulate from Hold at Johnson Rice
11/15/16
11/15/16
UPGRADE

Accumulate
Dollar Tree upgraded to Accumulate on Family Dollar progress at Johnson Rice
As previously reported, Johnson Rice upgraded Dollar Tree to Accumulate from Hold. Analyst David Mann has increased confidence in the long-term transformation at Family Dollar, the strong management team, lower investor expectations, and more attractive valuation.
11/22/16
FBCO
11/22/16
NO CHANGE
Target $75
FBCO
Underperform
Dollar Tree 'not worth chasing' after better than feared Q3, says Credit Suisse
Credit Suisse analyst Edward Joseph Kelly Jr. noted that Dollar Tree's Q3 results were "better than feared," as improvement at the core brand offset Family Dollar brand softness, but he believes the stock appears to be overreacting. Family Dollar still has challenges and the turnaround the market is assuming will be hard, said Kelly, who keeps an Underperform rating on the stock but raised his price target to $75 from $69 on the Dollar Tree shares.
WMT Wal-Mart
$70.12

0.75 (1.08%)

10/21/16
10/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CBS (CBS) initiated with a Buy at Wunderlich. 2. Wal-Mart (WMT) initiated with a Neutral at Piper Jaffray with analyst Sean Naughton citing "persistent declines" in U.S. operating margin and falling returns on incremental capital for his Neutral rating. 3. Asure Software (ASUR) initiated with a Buy at Roth Capital. 4. Valvoline (VVV) initiated with a Neutral at JPMorgan and a Neutral at Longbow. 5. Abraxas Petroleum (AXAS) initiated with a Buy at Rodman & Renshaw. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/27/16
JPMS
10/27/16
DOWNGRADE
Target $28
JPMS
Neutral
JPMorgan downgrades Vitamin Shoppe on 2017 earnings risk
JPMorgan analyst Christopher Horvers earlier today downgraded Vitamin Shoppe (VSI) to Neutral from Overweight and lowered his price target for the shares to $28 from $33. The analyst sees downside risk to 2017 earnings as the competitive environment worsens. GNC Holdings (GNC) under new management is testing major pricing and loyalty card changes while Vitamin Shoppe's comparable prices are higher versus Amazon (AMZN), Horvers tells investors in a research note. He sees Vitamin Shoppe "squeezed between" its three larger competitors, GNC, Wal-Mart (WMT) and Amazon. The stock is trading down $2.05 to $25.30 following GNC's Q3 results. GNC is trading down 20% to $16.04.
11/11/16
BARD
11/11/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart 2017 earnings somewhat de-risked, says Baird
Baird analyst Peter Benedict expects Wal-Mart's Q3 results to be generally in-line as investments in associates, processes, and prices are working together to drive improved customer satisfaction and sales. The company's 2017 estimates appear to be de-risked as management reset margin and earnings expectations at last month's investor meeting, said Benedict, who reiterated his Outperform rating and $80 price target on Wal-Mart shares.
11/17/16
BARD
11/17/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart strategy remains on track, says Baird
Baird analyst Peter Benedict notes that this was a 'noisy' quarter for Wal-Mart, but underlying EPS effectively in line with expectations. While acknowledging that U.S. traffic gains slowed against a tougher compare and Q4 EPS guidance was viewed as a disappointment, the analyst believes Wal-Mart's strategy remains on track and 2017 EPS estimates appear largely de-risked. He reiterates an Outperform rating and $80 price target on the shares, given the company's defensive appeal within a still choppy consumer/retail backdrop.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.